Each and every week I bring to you tech winners with great fundamentals.
However, perusing balance sheets and income statements isn’t the only way to find great stocks.
There’s also the technique known as technical analysis.
In technical analysis, we study a stock’s chart to figure out if it’s about to soar, ready to plummet or just treading water. And in my 30 years knocking around Silicon Valley, I’ve found that the stocks with the best charts tend to be small caps.
But not all stocks with eye-popping charts are risky small caps.
In fact, my charts have revealed two big-cap tech stocks with small-cap charts
Choosing the best stock to buy to play the commercial space race has enormous upside potential for investors.
That’s because the private space industry is worth billions. Just check out Tuesday’s news that NASA awarded Boeing Co. (NYSE: BA) and SpaceX – which is backed by Tesla (Nasdaq: TSLA) CEO Elon Musk – a whopping $6.8 billion contract for its Commercial Crew program.
In the 1989 classic flick Field of Dreams, Ray (played by Kevin Costner) hears a whisper from his cornfield. “If you build it, he will come,” the voice says.
After Ray builds his baseball field, he does indeed come – along with a baseball team and whole bunch of other folks.
It’s one of the best Hollywood stories ever, but it doesn’t always work that way in business.
Now that both Google Inc. (NasdaqGS: GOOG) and Apple Inc. (NasdaqGS: AAPL) have built a mobile-payments system, they’re waiting to see if anybody comes.
EMarketer researchers project U.S. mobile payments to increase from $1.6 billion last year to well over $110 billion in 2018. And Gartner projects global mobile payments to jump from $325 billion this year to more than $500 billion in 2016.
With so much money at stake, it’s no wonder Google and Apple are about to engage in a huge global battle over which company’s e-wallet platform consumers will choose to make purchases with their smartphones and tablets.
We could wait on the sidelines to see which e-wallet consumers “come” to.
But that’s not our style.
Instead, I have identified a “secret” play whose business will be supercharged no matter who wins the mobile-payments war.
If you had bought Biogen Idec Inc. (NasdaqGS: BIIB) during the depths of this spring’s biotech selloff, you could have been sitting on peak gains of 28.3%.
If you’d picked up Celgene Corp. (NasdaqGS: CELG) at the time, you’d be doing even better, with peak gains of 40.9%.
And if you had been really brave, you could have picked up shares of the company that – through a series of Washington political shenanigans – was the “cause” of the selloff. And you’d be doing very well, indeed.
Since April 11, Gilead Sciences Inc. (NasdaqGS: GILD) has scored peak gains of a whopping 74.2% – or more than 175% annualized gains.
But some investors don’t want to risk it all during a selloff by picking and choosing among stocks getting slammed – but they still do want to take advantage of the growth hot biotech stocks offer.
So today I want to tell you about a conservative approach to investing.
However, though this investment is conservative, it still offers big money through biotech.
Tesla Motors Inc. stock hit a new high on Aug. 29 thanks to very positive news out of China.
The world leader in electric vehicles is set to install 400 charging stations in roughly 120 Chinese cities. And that’s on top of 200 charging stations Tesla already operates in the world’s most populous nation.
The news comes just weeks after Tesla began selling its luxurious $70,000 Model S in China.
So far this year, Tesla shares are up more than 80%. And its Chinese expansion should propel the stock even further – in fact, I think China will become Tesla’s biggest market within the next year.
But that performance, as impressive as it is, pales in comparison to the performance of a Chinese auto e-commerce company I told you about Feb. 4.
Since then, your shares have gone on a tear, rising some 220%.